Novo Nordisk Hires US Pharma Exec Amid Pricing Pressure

Novo Nordisk hires U.S. pharma veteran Greg Miley to head corporate affairs amid pricing pressures and White House scrutiny. Find out how this strategic move, coupled with a major restructuring and job cuts, aims to regain investor confidence and tackle competition from Eli Lilly in the booming obesity drug market. Will Miley's experience be enough to navigate Trump's demands for lower drug costs and protect Novo's bottom line?The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.